Listed

Biolargo, Inc.

BLGOOTCCIK 880242MaterialsFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$1.2mRevenue, Q2 FY2026, three months to 2026-06-30$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 14, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$1.2mRevenue, Q2 FY2026, three months to 2026-06-30$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Report this figure−55.1% on a year earlier
  • Gross margin54.1%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $675.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Report this figure+2.9 pts on a year earlier
  • Operating margin−298.7%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Report this figure−233.8 pts on a year earlier
  • Net margin−320.5%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$4.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Report this figure−252.7 pts on a year earlier
  • Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$1.2mGross margin 54.1%
Biolargo, Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$k4,351Revenue, Q3 FY2024, three months to 2024-09-30$4.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-14, accession 0001437749-25-035239.Report this figure3,657Revenue, Q4 FY2024, three months to 2024-12-31$3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926. Derived: 12-month figure less the 9-month figure.Report this figure3,269Revenue, Q1 FY2025, three months to 2025-03-31$3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-15, accession 0001437749-26-017391.Report this figure2,777Revenue, Q2 FY2025, three months to 2025-06-30$2.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Report this figure1,103Revenue, Q3 FY2025, three months to 2025-09-30$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-14, accession 0001437749-25-035239.Report this figure617Revenue, Q4 FY2025, three months to 2025-12-31$617.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926. Derived: 12-month figure less the 9-month figure.Report this figure1,115Revenue, Q1 FY2026, three months to 2026-03-31$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-15, accession 0001437749-26-017391.Report this figure1,248Revenue, Q2 FY2026, three months to 2026-06-30$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Report this figure
Gross margin%39.6%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $1.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001437749-25-035239.Revenue: $4.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-14, accession 0001437749-25-035239.Report this figure47.9%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $1.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-04, accession 0001437749-26-006926. Derived: 12-month figure less the 9-month figure.Revenue: $3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926. Derived: 12-month figure less the 9-month figure.Report this figure45.5%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $1.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-15, accession 0001437749-26-017391.Revenue: $3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-15, accession 0001437749-26-017391.Report this figure51.2%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $1.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Revenue: $2.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Report this figure33.7%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $372.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001437749-25-035239.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-14, accession 0001437749-25-035239.Report this figure20.7%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $128.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-04, accession 0001437749-26-006926. Derived: 12-month figure less the 9-month figure.Revenue: $617.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926. Derived: 12-month figure less the 9-month figure.Report this figure41.1%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $458.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-15, accession 0001437749-26-017391.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-15, accession 0001437749-26-017391.Report this figure54.1%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $675.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Report this figure
Operating margin%(24.4%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001437749-25-035239.Revenue: $4.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-14, accession 0001437749-25-035239.Report this figure(44.2%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001437749-26-006926. Derived: 12-month figure less the 9-month figure.Revenue: $3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926. Derived: 12-month figure less the 9-month figure.Report this figure(57.0%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001437749-26-017391.Revenue: $3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-15, accession 0001437749-26-017391.Report this figure(64.9%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Revenue: $2.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Report this figure(651.0%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$7.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001437749-25-035239.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-14, accession 0001437749-25-035239.Report this figure(650.1%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001437749-26-006926. Derived: 12-month figure less the 9-month figure.Revenue: $617.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926. Derived: 12-month figure less the 9-month figure.Report this figure(287.4%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001437749-26-017391.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-15, accession 0001437749-26-017391.Report this figure(298.7%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Report this figure
Net margin%(24.4%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$1.1m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2025-11-14, accession 0001437749-25-035239.Revenue: $4.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-14, accession 0001437749-25-035239.Report this figure(47.4%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$1.7m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-03-04, accession 0001437749-26-006926. Derived: 12-month figure less the 9-month figure.Revenue: $3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926. Derived: 12-month figure less the 9-month figure.Report this figure(58.8%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$1.9m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-05-15, accession 0001437749-26-017391.Revenue: $3.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-15, accession 0001437749-26-017391.Report this figure(67.8%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$1.9m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Revenue: $2.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Report this figure(656.8%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$7.2m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2025-11-14, accession 0001437749-25-035239.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-14, accession 0001437749-25-035239.Report this figure(671.3%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$4.1m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-03-04, accession 0001437749-26-006926. Derived: 12-month figure less the 9-month figure.Revenue: $617.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926. Derived: 12-month figure less the 9-month figure.Report this figure(305.4%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$3.4m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-05-15, accession 0001437749-26-017391.Revenue: $1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-15, accession 0001437749-26-017391.Report this figure(320.5%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$4.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Revenue: $1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-14, accession 0001437749-26-028023.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)
Free cash flow$knot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$7.8mGross margin 43.9%
Diluted EPS−$0.03, FY2021
Biolargo, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m2.5Revenue, FY2021, twelve months to 2021-12-31$2.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2023-03-31, accession 0001437749-23-008876.Report this figure5.9Revenue, FY2022, twelve months to 2022-12-31$5.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-04-01, accession 0001437749-24-010394.Report this figure12.2Revenue, FY2023, twelve months to 2023-12-31$12.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-04-01, accession 0001437749-24-010394.Report this figure17.8Revenue, FY2024, twelve months to 2024-12-31$17.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926.Report this figure7.8Revenue, FY2025, twelve months to 2025-12-31$7.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926.Report this figure
Gross margin%43.6%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $1.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-03-31, accession 0001437749-23-008876.Revenue: $2.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2023-03-31, accession 0001437749-23-008876.Report this figure48.6%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $2.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-04-01, accession 0001437749-24-010394.Revenue: $5.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-04-01, accession 0001437749-24-010394.Report this figure50.3%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $6.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-31, accession 0001437749-25-010172.Revenue: $12.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-04-01, accession 0001437749-24-010394.Report this figure44.2%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $7.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-04, accession 0001437749-26-006926.Revenue: $17.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926.Report this figure43.9%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $3.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-04, accession 0001437749-26-006926.Revenue: $7.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926.Report this figure
Operating margin%(267.8%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$6.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-31, accession 0001437749-23-008876.Revenue: $2.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2023-03-31, accession 0001437749-23-008876.Report this figure(91.6%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$5.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-04-01, accession 0001437749-24-010394.Revenue: $5.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-04-01, accession 0001437749-24-010394.Report this figure(37.4%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001437749-25-010172.Revenue: $12.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-04-01, accession 0001437749-24-010394.Report this figure(24.4%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$4.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001437749-26-006926.Revenue: $17.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926.Report this figure(191.3%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$14.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-04, accession 0001437749-26-006926.Revenue: $7.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926.Report this figure
Net margin%(272.4%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$6.9m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2023-03-31, accession 0001437749-23-008876.Revenue: $2.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2023-03-31, accession 0001437749-23-008876.Report this figure(87.2%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$5.1m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2024-04-01, accession 0001437749-24-010394.Revenue: $5.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-04-01, accession 0001437749-24-010394.Report this figure(38.0%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$4.6m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2025-03-31, accession 0001437749-25-010172.Revenue: $12.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-04-01, accession 0001437749-24-010394.Report this figure(24.5%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$4.3m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-03-04, accession 0001437749-26-006926.Revenue: $17.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926.Report this figure(195.6%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$15.2m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-03-04, accession 0001437749-26-006926.Revenue: $7.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-04, accession 0001437749-26-006926.Report this figure
Diluted EPS$ per share(0.03)Diluted EPS, FY2021, twelve months to 2021-12-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasicAndDiluted. 10-K filed 2022-03-31, accession 0001437749-22-007726.Report this figurenot reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Dec 2024 to Nov 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Biolargo, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
FIRST AMERICAN TRUST, FSB2026-06-30$13.4k117,838Unchanged

Recent filings

All 884 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Biolargo, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-1910:01 ETDEF 14AProxy statementPeriod 2026-12-010001437749-26-032868
2026-09-1423:42 ET8-K/A7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-26-030198
2026-09-1114:38 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-26-030124
2026-08-1420:27 ET10-QQuarterly reportPeriod 2026-06-300001437749-26-028023
2026-05-1520:29 ET10-QQuarterly reportPeriod 2026-03-310001437749-26-017391
2026-05-0610:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-26-014996
2026-05-0411:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-26-014540
2026-04-3020:02 ET10-K/AAnnual report, amendedPeriod 2025-12-310001437749-26-014184
2026-04-0918:50 ETS-1Registration statement0001437749-26-011880
2026-04-0918:35 ETS-1Registration statement0001437749-26-011875

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 4, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
880242
Tickers
BLGO
Exchange
OTC
SIC code
2800 Chemicals & Allied Products
Sector
Materials
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Non-accelerated filer<br>Smaller reporting company
Former names
NUWAY MEDICAL INC (to 2007-04-03); NUWAY ENERGY INC (to 2003-02-05); LATIN AMERICAN CASINOS INC (to 2001-02-15)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:26 ET. Listed shows no prices and gives no investment advice.